HHS Secretary Robert F. Kennedy Jr. asked the FDA "to review the latest data on mifepristone ," but experts say concerns about the abortion pill's safety are misguided.

AAPLOG Vice Chair Dr. Susan Bane discusses the potential health risks of abortion drugs like mifepristone on ‘Fox & Friends ...

WEDNESDAY, July 16, 2025 (HealthDay News) — A federal appeals court has ruled that West Virginia can limit access to ...

Pro-life medical groups are urging Health and Human Services Secretary Robert Kennedy Jr. to reexamine the FDA’s broad ...

A top official at the U.S. Food and Drug Administration (FDA) confirmed on Monday that the organization will conduct a review of the abortion drug mifepristone following several recent studies ...

Good news for activists after Trump administration disappointments. "For us to once again federalize the issue of abortion without a clear directive from Congress, right on the heels of Dobbs, would ...

The US Food and Drug Administration held off a legal challenge from a coalition of blue states over the abortion pill, ...

By questioning the FDA's authority to regulate an abortion drug, ... "The FDA approval process is one that is based on extensive, evidence-based, scientific review of efficacy and safety.

As abortion-rights activists have pushed to loosen the FDA safety protocols, pro-life advocates have begun pushing in the opposite direction, rightly noting the potentially grave hazards to women ...

At the same time, the FDA announced that it is gutting safety requirements for the two chemical-abortion drugs — mifepristone and misoprostol — in response to a pressure campaign from pro ...

Appeals court embraces abortion-pill limits, sets up Supreme Court review. The Supreme Court has ruled that mifepristone, a key abortion drug, will remain available for now under existing rules ...